Skip to content
Evigrade
ModerateAlpha and beta blocker (non-selective β + α1)×Atypical antipsychotic – thienobenzodiazepine

Updated · Methodology

Mechanism

Carvedilol lowers blood pressure. According to its SmPC, it can increase the effect of other drugs that lower blood pressure or cause hypotension as an adverse effect (carvedilol SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Olanzapine can cause orthostatic hypotension, probably through alpha1-adrenergic blockade. In clinical studies, it was recorded in 20% or more of adults taking oral olanzapine (olanzapine label, US Food and Drug Administration, FDA). The European SmPC lists orthostatic hypotension among the most frequent adverse reactions of olanzapine (olanzapine SmPC, European Medicines Agency, EMA). The US olanzapine label states that olanzapine may increase the effects of certain antihypertensive drugs (olanzapine label, FDA). The documents say nothing about either drug changing the levels of the other. Olanzapine does not inhibit the main CYP enzymes (olanzapine SmPC, EMA).

Symptoms

Dizziness, a fast or slow heartbeat and fainting can occur on standing up, especially early in olanzapine dose titration (olanzapine label, US Food and Drug Administration, FDA). With carvedilol, hypotension is a very common adverse reaction and orthostatic hypotension is common. Carvedilol can also cause bradycardia (carvedilol SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Olanzapine can cause sleepiness, orthostatic hypotension and unsteadiness, which can lead to falls and fractures (olanzapine label, FDA).

Management

The combination is acceptable but needs caution. The US olanzapine label asks for particular caution in people taking antihypertensive drugs, and for caution in people taking other drugs that can cause hypotension or bradycardia (olanzapine label, US Food and Drug Administration, FDA). Carvedilol can increase the blood pressure drop caused by olanzapine (carvedilol SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Monitor blood pressure. In people over 65, measure it periodically (olanzapine SmPC, European Medicines Agency, EMA). In people aged 65 or over, consider a lower starting dose of olanzapine, 5 mg per day, when clinical factors warrant it (olanzapine SmPC, EMA). According to the US olanzapine label, starting at 5 mg once daily may reduce the risk of orthostatic hypotension and syncope. If hypotension occurs, consider a slower dose increase (olanzapine label, FDA). Start carvedilol at a low dose and increase it at intervals of at least two weeks. In heart failure, give carvedilol with food to reduce orthostatic effects (carvedilol SmPC, AEMPS). If the pulse falls below 55 beats per minute, reduce the carvedilol dose (carvedilol SmPC, AEMPS). When starting olanzapine in people whose diseases or other drugs could worsen sleepiness, orthostatic hypotension or unsteadiness, assess the risk of falls. Repeat the assessment during long-term treatment (olanzapine label, FDA). Advise the patient to change position slowly and, if they feel dizzy or faint, to lie down until they feel better (olanzapine label, FDA).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Carvedilol

Other interactions with Olanzapine